Swiss Liver Center, Department of Hepatology, University Clinic for Visceral Surgery and Medicine, Inselspital, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Institute for Pathology, University of Bern, Bern, Switzerland.
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2101-2109.e1. doi: 10.1016/j.cgh.2018.12.038. Epub 2019 Jan 6.
BACKGROUND & AIMS: Patients with hepatic venous pressure gradients (HVPGs) of 10 mm Hg or greater and chronic liver disease often are assumed to have cirrhosis. We investigated the association between HVPGs and cirrhosis, using histologic findings as the reference standard. We also assessed the prevalence and characteristics of patients with HVPGs of 10 mm Hg or greater without cirrhosis.
We performed a retrospective analysis of 157 consecutive patients, 89 with suspected cirrhosis and hepatic hemodynamic data collected from 2015 through 2017. Biopsy specimens collected had 10 or more portal tracts from each patient and were analyzed for features of cirrhosis. Biopsy specimens with histologic features of cirrhosis were excluded and the remaining biopsy specimens were re-reviewed by an expert pathologist. The fibrosis area was calculated digitally by image analysis.
HVPG identified patients with cirrhosis with an area under the receiver operating characteristic curve of 0.879: 14 of 89 patients with HVPG of 10 mm Hg or greater (16%) had no histologic features of cirrhosis (METAVIR scores <4 and Ishak scores <6). The median HVPG was 11 mm Hg (range, 10-22 mm Hg). Based on METAVIR scores, 7 patients had fibrosis stage F3, 4 patients had fibrosis stage F2, and 3 patients had fibrosis stages F0 or F1. The mean area of fibrosis in livers was 16.2% ± 6.5%. All 14 patients had perisinusoidal fibrosis and 8 patients had hepatocyte ballooning. The most common diagnoses were nonalcoholic steatohepatitis (n = 5) and nodular regenerative hyperplasia (n = 4). An HVPG cut-off value of 12 mm Hg identified patients with cirrhosis with 92% specificity, misclassifying 5 patients with different etiologies of liver disease.
In a retrospective analysis of 89 consecutive patients with chronic liver disease and an HVPG of 10 mm Hg or greater, 16% were not found to have cirrhosis upon biopsy analysis. Most of these patients had nonalcoholic steatohepatitis or nodular regenerative hyperplasia. Perisinusoidal fibrosis and hepatocyte ballooning might increase sinusoidal pressure. An HVPG cut-off value of 12 mm Hg or greater identified patients with cirrhosis with 92% specificity.
肝静脉压力梯度(HVPG)为 10mmHg 或更高且患有慢性肝病的患者通常被认为患有肝硬化。我们使用组织学发现作为参考标准,研究了 HVPG 与肝硬化之间的关系。我们还评估了 HVPG 为 10mmHg 或更高但无肝硬化的患者的患病率和特征。
我们对 157 例连续患者进行了回顾性分析,其中 89 例疑似肝硬化,2015 年至 2017 年收集了肝血流动力学数据。每位患者的活检标本均采集了 10 个或更多的门管区,并分析了肝硬化的特征。排除具有肝硬化组织学特征的活检标本,由一位专家病理学家重新审查剩余的活检标本。通过图像分析数字化计算纤维面积。
HVPG 对肝硬化患者的诊断准确性为 0.879(ROC 曲线下面积):89 例 HVPG 为 10mmHg 或更高的患者中有 14 例(16%)无肝硬化组织学特征(METAVIR 评分<4 且 Ishak 评分<6)。HVPG 的中位数为 11mmHg(范围,10-22mmHg)。根据 METAVIR 评分,7 例患者纤维化分期 F3,4 例患者纤维化分期 F2,3 例患者纤维化分期 F0 或 F1。肝脏纤维化面积平均值为 16.2%±6.5%。所有 14 例患者均有窦周纤维化,8 例患者有肝细胞气球样变。最常见的诊断为非酒精性脂肪性肝炎(n=5)和结节性再生性增生(n=4)。HVPG 截断值为 12mmHg 时,92%特异性地识别出肝硬化患者,误诊了 5 例不同病因的肝病患者。
在对 89 例连续慢性肝病和 HVPG 为 10mmHg 或更高的患者进行回顾性分析中,16%的患者在活检分析中未发现肝硬化。这些患者大多数患有非酒精性脂肪性肝炎或结节性再生性增生。窦周纤维化和肝细胞气球样变可能会增加窦状隙压力。HVPG 截断值为 12mmHg 或更高时,92%特异性地识别出肝硬化患者。